newsfilter
← Latest News
Business Wire·

Glancy Binkow & Goldberg LLP Announces Investigation on Behalf of Shareholders of Aegerion Pharmaceuticals, Inc.

LOS ANGELES--(BUSINESS WIRE)--Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of shareholders of Aegerion Pharmaceuticals, Inc. (“Aegerion” or the “Company”) (NASDAQ:AEGR) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by Aegerion concerning the Company’s operations and financial performance and prospects.